Bibliotecas PUC-SP - Busca Integrada

Presentacion

Por Pilar Garrido, Dolores Isla
Publicado no Arbor: Ciencia, Pensamiento y Cultura (2015-06-01)

Factores de riesgo de deterioro cognitivo asociado a cáncer en pacientes con carcinoma de mama y colon que reciben tratamiento con quimioterapia

Por Patricia Iranzo, Ana Callejo, Julio Arbej, Sebastian Menao, Dolores Isla, Raquel Andrés
Publicado no Anales del Sistema Sanitario de Navarra (2023-08-01)

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

Por Dolores Isla, Alfredo Sánchez, Joaquín Casal, Manuel Cobo, Margarita Majem, Noemi Reguart, Jon Zugazagoitia, Reyes Bernabé
Publicado no Journal of Clinical Medicine (2023-08-01)

Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain

Por Dolores Isla, Marta Lopez-Brea, María Espinosa, Natalia Arrabal, Diego Pérez-Parente, David Carcedo, Reyes Bernabé-Caro
Publicado no Cost Effectiveness and Resource Allocation (2023-01-01)

Thermal Liquid Biopsy (TLB): A Predictive Score Derived from Serum Thermograms as a Clinical Tool for Screening Lung Cancer Patients

Por Alberto Rodrigo, Jorge L. Ojeda, Sonia Vega, Oscar Sanchez-Gracia, Angel Lanas, Dolores Isla, Adrian Velazquez-Campoy, Olga Abian
Publicado no Cancers (2019-07-01)

Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic review

Por Rita Leporati, Édouard Auclin, Daniel Morchón, Miquel Ferriol-Galmés, Juan Carlos Laguna, Teresa Gorria, Cristina Teixidó, Maria Aranzazu Amores, Paolo Ambrosini, Dolores Isla, Giuseppe Lo Russo, Laura Mezquita
Publicado no Therapeutic Advances in Medical Oncology (2024-12-01)

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells

Por Cecilia Pesini, Sandra Hidalgo, Maykel A. Arias, Llipsy Santiago, Carlota Calvo, Maitane Ocariz-Díez, Dolores Isla, Pilar M. Lanuza, M José Agustín, Eva M Galvez, Ariel Ramírez-Labrada, Julián Pardo
Publicado no OncoImmunology (2022-12-01)

Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients

Por Marta Gascón-Ruiz, Diego Casas-Deza, Maria Marti-Pi, Irene Torres-Ramón, María Zapata-García, Andrea Sesma, Julio Lambea, María Álvarez-Alejandro, Elisa Quilez, Dolores Isla, Jose Miguel Arbonés-Mainar
Publicado no Biomedicines (2022-09-01)

Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

Por Marta Gascón, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, Alfonso Yubero, Julián Pardo, Luis Martínez-Lostao
Publicado no Cells (2020-06-01)

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

Por Glenwood D. Goss, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Dolores Isla, Alessandro Morabito, Young J. Min, Andrea Ardizzoni, Shaun Bender, Agnieszka Cseh, Enriqueta Felip
Publicado no EClinicalMedicine (2021-07-01)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

Por Maitane Ocáriz-Díez, Maitane Ocáriz-Díez, Mara Cruellas, Mara Cruellas, Marta Gascón, Marta Gascón, Rodrigo Lastra, Rodrigo Lastra, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Luis Martínez-Lostao, Ariel Ramírez-Labrada, José Ramón Paño, José Ramón Paño, Andrea Sesma, Andrea Sesma, Irene Torres, Irene Torres, Alfonso Yubero, Alfonso Yubero, Julián Pardo, Julián Pardo, Julián Pardo, Julián Pardo, Dolores Isla, Dolores Isla, Eva M. Gálvez
Publicado no Frontiers in Oncology (2020-09-01)

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

Por Margarita Majem, Manuel Cobo, Dolores Isla, Diego Marquez-Medina, Delvys Rodriguez-Abreu, Joaquín Casal-Rubio, Teresa Moran Bueno, Reyes Bernabé-Caro, Diego Pérez Parente, Pedro Ruiz-Gracia, Marta Marina Arroyo, Luis Paz-Ares
Publicado no Journal of Clinical Medicine (2021-03-01)

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

Por Andrea Sesma, Julián Pardo, Mara Cruellas, Eva M. Gálvez, Marta Gascón, Dolores Isla, Luis Martínez-Lostao, Maitane Ocáriz, José Ramón Paño, Elisa Quílez, Ariel Ramírez, Irene Torres-Ramón, Alfonso Yubero, María Zapata, Rodrigo Lastra
Publicado no Cancers (2020-10-01)

Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis

Por Natalia Alonso, Natalia Alonso, Sebastián Menao, Sebastián Menao, Rodrigo Lastra, Rodrigo Lastra, María Arruebo, María P. Bueso, María P. Bueso, Esther Pérez, M. Laura Murillo, M. Laura Murillo, María Álvarez, María Álvarez, Alba Alonso, Soraya Rebollar, Mara Cruellas, Mara Cruellas, Dolores Arribas, Mónica Ramos, Dolores Isla, Dolores Isla, Juan José Galano-Frutos, Juan José Galano-Frutos, Helena García-Cebollada, Helena García-Cebollada, Javier Sancho, Javier Sancho, Javier Sancho, Raquel Andrés, Raquel Andrés
Publicado no Frontiers in Genetics (2024-02-01)

A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer

Por Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra, Luis Martínez-Lostao, J. Ramón Paño-Pardo, Andrea Sesma, María Zapata-García, Alba Moratiel, Elisa Quílez, Irene Torres-Ramón, Alfonso Yubero, María Pilar Domingo, Patricia Esteban, Eva M. Gálvez, Julián Pardo, Dolores Isla
Publicado no Cancers (2023-01-01)

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Por Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassilis Georgoulias, Wei Li, Dolores Isla, Salih Z Guclu, Alessandro Morabito, Young J Min, Andrea Ardizzoni, Shirish M Gadgeel, Bushi Wang, Vikram K Chand, Glenwood D Goss
Publicado no Современная онкология (2015-09-01)

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Por Edurne Arriola, Ramón García Gómez, Pilar Diz, Margarita Majem, Maite Martínez Aguillo, Javier Valdivia, Alfredo Paredes, José Miguel Sánchez-Torres, Sergio Peralta Muñoz, Isidoro Barneto, Vanesa Gutierrez, Jesús Manuel Andrade Santiago, Francisco Aparisi, Dolores Isla, Santiago Ponce, David Vicente Baz, Angel Artal, Mariluz Amador, Mariano Provencio
Publicado no BMC Cancer (2018-01-01)

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Por Pilar Garrido, Luis Paz‐Ares, Margarita Majem, Teresa Morán, José Manuel Trigo, Joaquim Bosch‐Barrera, Rosario Garcίa‐Campelo, José Luis González‐Larriba, José Miguel Sánchez‐Torres, Dolores Isla, Núria Viñolas, Carlos Camps, Amelia Insa, Óscar Juan, Bartomeu Massuti, Alfredo Paredes, Ángel Artal, Marta López‐Brea, José Palacios, Enriqueta Felip
Publicado no Cancer Medicine (2021-09-01)

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Por Aida Piedra, Aida Piedra, Sergio Martínez-Recio, Ainhoa Hernández, Teresa Morán, Edurne Arriola, Jordi Recuero-Borau, Manuel Cobo, Patricia Cordeiro, Joaquín Mosquera, Manuel Fernández, Rosario García-Campelo, Antonio Calles, Rosa Álvarez, María Zapata-García, Dolores Isla, Ana Callejo, Patricia Iranzo, Jorgina Serra-López, Andrés Barba, Ivana Sullivan, Enriqueta Felip, Margarita Majem
Publicado no Frontiers in Oncology (2024-12-01)

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

Por Rafael Rosell, Laia Perez-Roca, Jose Javier Sanchez, Manuel Cobo, Teresa Moran, Imane Chaib, Mariano Provencio, Manuel Domine, Maria Angeles Sala, Ulpiano Jimenez, Pilar Diz, Isidoro Barneto, Jose Antonio Macias, Ramon de Las Peñas, Silvia Catot, Dolores Isla, Jose Miguel Sanchez, Rafael Ibeas, Guillermo Lopez-Vivanco, Juana Oramas, Pedro Mendez, Noemi Reguart, Remei Blanco, Miquel Taron
Publicado no PLoS ONE (2009-01-01)